4//SEC Filing
Stephan Dietrich A 4
Accession 0001104659-23-033856
CIK 0001173281other
Filed
Mar 16, 8:00 PM ET
Accepted
Mar 17, 4:11 PM ET
Size
7.2 KB
Accession
0001104659-23-033856
Insider Transaction Report
Form 4
Stephan Dietrich A
DirectorPresident and CEO10% Owner
Transactions
- Award
Common stock
2023-03-16+153,000→ 153,000 total
Holdings
- 1,471,775
Common stock
- 1,273,819(indirect: See footnote)
Common stock
Footnotes (3)
- [F1]Restricted stock units to be settled by the issuance of one share of common stock for each restricted stock unit that is earned; 25% of which shall vest on March 16, 2024 and the remainder of which shall vest monthly thereafter until March 16, 2027, provided that vesting shall only occur on a scheduled vesting date if employment has not terminated prior to such vesting date, inclusive. Restricted stock units are subject to accelerated vesting, subject to certain conditions, in the event of a change of control of the Issuer.
- [F2]Shares held by the reporting person as a tenant by the entirety with his spouse.
- [F3]These shares are held in an irrevocable trust in which the spouse of the reporting person is the investment trustee, and the spouse and the descendants of the reporting person are its beneficiaries, and another irrevocable trust in which the reporting person is the investment trustee, and the reporting person and the descendants of the reporting person's spouse are its beneficiaries.
Documents
Issuer
NeuBase Therapeutics, Inc.
CIK 0001173281
Entity typeother
Related Parties
1- filerCIK 0001774588
Filing Metadata
- Form type
- 4
- Filed
- Mar 16, 8:00 PM ET
- Accepted
- Mar 17, 4:11 PM ET
- Size
- 7.2 KB